Suppressing hemangio- & lymphangiogenesis by splice MO against VEGFR2 (KDR)

4 posts / 0 new
Last post
Jon Moulton
Jon Moulton's picture
Suppressing hemangio- & lymphangiogenesis by splice MO against VEGFR2 (KDR)

Uehara H, Cho Y, Simonis J, Cahoon J, Archer B, Luo L, Das SK, Singh N, Ambati J, Ambati BK.  Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR).  FASEB J, 2012;[Epub ahead of print] doi:10.1096/fj.12-213835

sarmed
sarmed's picture
hi would you help me out with
Jon Moulton
Jon Moulton's picture
It's an interesting question,

It's an interesting question, Sarmed, but I don't want to speculate about human treatments for performance enhancement.

sarmed
sarmed's picture
 ok .... so I was wondering :

 ok .... so I was wondering :

1) Viral transfection is the best type for in vivo transfection as far as effectivity so what's gonna happen for the letiviral or adeno-virus after transfection is done and the targeted gene has been knocked-out?

2) Which one of the other methods comes in the second place

3) what is  the best way  to active immunize against some gene ... better than risking knock it out while we can only make the immune syste  produce some antibodies against it????